Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 51,331,500
  • Shares Outstanding, K 395,710
  • Annual Sales, $ 60,210 K
  • Annual Income, $ -514,020 K
  • 60-Month Beta 1.73
  • Price/Sales 192.31
  • Price/Cash Flow N/A
  • Price/Book 17.86
Trade MRNA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.18
  • Number of Estimates 7
  • High Estimate 0.17
  • Low Estimate -0.75
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +51.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
102.66 +26.76%
on 12/31/20
147.26 -11.63%
on 12/21/20
-17.09 (-11.61%)
since 12/15/20
3-Month
65.49 +98.70%
on 10/28/20
178.50 -27.10%
on 12/01/20
+54.55 (+72.18%)
since 10/15/20
52-Week
17.91 +626.58%
on 02/21/20
178.50 -27.10%
on 12/01/20
+109.89 (+542.93%)
since 01/15/20

Most Recent Stories

More News
Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know

Moderna (MRNA) closed at $124.06 in the latest trading session, marking a -0.39% move from the prior day.

MRNA : 130.06 (+0.26%)
Stock Market News for Jan 13, 2021

Benchmarks closed in the positive territory on Tuesday as investors remained optimistic on possible fiscal stimulus and vaccine roll out.

JPM : 139.41 (-1.25%)
TRV : 144.03 (+1.20%)
GS : 301.60 (-2.04%)
BAC : 33.07 (-2.71%)
INTC : 57.90 (-2.28%)
BIDU : 238.31 (-4.29%)
MRNA : 130.06 (+0.26%)
DOCU : 248.21 (-0.82%)
Thinking about trading options or stock in Nio, Ford Motor, Johnson & Johnson, Moderna, or General Motors?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NIO, F, JNJ, MRNA, and GM.

MRNA : 130.06 (+0.26%)
F : 9.94 (-2.26%)
GM : 50.28 (-2.43%)
JNJ : 160.78 (+0.08%)
NIO : 56.05 (-7.92%)
Flat Session Gets Market Back in the Green

Flat Session Gets Market Back in the Green

DNOW : 8.93 (-3.25%)
RYAM : 7.43 (-2.49%)
SQQQ : 15.23 (+1.80%)
MHK : 148.83 (-2.07%)
OSTK : 59.38 (-7.32%)
GS : 301.60 (-2.04%)
MU : 80.96 (-0.42%)
PFE : 36.71 (-0.11%)
MRNA : 130.06 (+0.26%)
NVAX : 127.42 (-1.97%)
JPM : 139.41 (-1.25%)
C : 64.69 (-6.26%)
WFC : 32.16 (-7.45%)
PNC : 156.34 (-3.20%)
Markets Prove Buoyant; KB Home (KNH) Beats Q4 Estimates

KB Home's $1.12 per share was well out in front of the 87 cents in the Zacks consensus, while revenues of $1.19 billion topped the $1.11 billion expected.

MRNA : 130.06 (+0.26%)
KBH : 35.68 (+1.11%)
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

PFE : 36.71 (-0.11%)
MRNA : 130.06 (+0.26%)
LLY : 191.29 (+2.46%)
IBB : 161.95 (+0.05%)
CNCR : 34.59 (-1.17%)
XBI : 152.15 (-0.83%)
BBH : 181.22 (+0.67%)
FBT : 176.46 (+0.14%)
SBIO : 56.28 (-0.92%)
PBE : 76.08 (-0.20%)
BTEC : 63.80 (-0.56%)
ARKG : 108.33 (-0.89%)
BNTX : 102.00 (-3.64%)
COVID-19 Vaccine Production to Ramp Up

COVID-19 Vaccine Production to Ramp Up

PFE : 36.71 (-0.11%)
MRNA : 130.06 (+0.26%)
BNTX : 102.00 (-3.64%)
Covid-19 Vaccinations Promise to Ramp Up

Guidance for the end of 2020 was to have 20 million Americans with the first half of the two-injection immunization treatment; as of now, only around 9 million Americans have received the first dose.

PFE : 36.71 (-0.11%)
MRNA : 130.06 (+0.26%)
BNTX : 102.00 (-3.64%)
Moderna (MRNA) Stock Up on Vaccine Pipeline Expansion Plan

Moderna (MRNA) plans to initiate clinical studies on new candidates as potential vaccine for seasonal flu, HIV and the Nipah virus.

JNJ : 160.78 (+0.08%)
AZN : 51.35 (+0.12%)
MRNA : 130.06 (+0.26%)
BNTX : 102.00 (-3.64%)
Jose M. Vega, M.D. Joins Moderna as Chief Safety Officer

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Jose M. Vega, M.D. joined Moderna as Chief Safety Officer effective...

MRNA : 130.06 (+0.26%)
MRK : 83.48 (+1.59%)
AMGN : 246.52 (+2.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA-...

See More

Key Turning Points

3rd Resistance Point 141.05
2nd Resistance Point 136.01
1st Resistance Point 132.87
Last Price 130.06
1st Support Level 124.69
2nd Support Level 119.65
3rd Support Level 116.51

See More

52-Week High 178.50
Last Price 130.06
Fibonacci 61.8% 117.15
Fibonacci 50% 98.21
Fibonacci 38.2% 79.26
52-Week Low 17.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar